Replimune Group, Inc. (REPL)

8.65 +0.58 (+7.19%) USD  |  NASDAQ  |  Mar 09, 13:14
More

Replimune Group Preferred Stock Dividend (% of Annual Revenues)

Preferred Stock Dividend (% of Annual Revenues) Chart

View Preferred Stock Dividend (% of Annual Revenues) for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Preferred Stock Dividend (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Preferred Stock Dividend (% of Annual Revenues) Range, Past 5 Years

View Preferred Stock Dividend (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Preferred Stock Dividend (% of Annual Revenues) Benchmarks

View Preferred Stock Dividend (% of Annual Revenues) Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade
REGENXBIO, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade